A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Evaluating the Efficacy and Safety of Orelabrutinib Plus R-CHOP Versus Placebo Plus R-CHOP in Treatment-Naïve Patients with Mcd Subtype Diffuse Large B-Cell Lymphoma
| العنوان: | A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study Evaluating the Efficacy and Safety of Orelabrutinib Plus R-CHOP Versus Placebo Plus R-CHOP in Treatment-Naïve Patients with Mcd Subtype Diffuse Large B-Cell Lymphoma |
|---|---|
| المؤلفون: | Pengpeng Xu, Ni Fan, Yamin Tian, Xinran Tang, Bin Zhang, Wei Zhou, Renbin Zhao, Weili Zhao |
| المصدر: | Blood. 140:12110-12110 |
| بيانات النشر: | American Society of Hematology, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Immunology, Cell Biology, Hematology, Biochemistry |
| تدمد: | 1528-0020 0006-4971 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::e5b779b5d1748b3f61c902722f5bdce7 https://doi.org/10.1182/blood-2022-158865 |
| رقم الأكسشن: | edsair.doi...........e5b779b5d1748b3f61c902722f5bdce7 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15280020 00064971 |
|---|